Westpac Banking Corp decreased its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 27.4% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,400 shares of the financial services provider’s stock after selling 3,930 shares during the quarter. Westpac Banking Corp’s holdings in CME Group were worth $2,725,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. BlackRock Inc. acquired a new position in CME Group in the second quarter valued at approximately $6,749,965,000. Bank of America Corp DE grew its stake in shares of CME Group by 39.1% during the 1st quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider’s stock worth $1,187,290,000 after purchasing an additional 1,130,587 shares during the period. Bank of New York Mellon Corp acquired a new stake in shares of CME Group during the 2nd quarter worth approximately $867,313,000. Alphabet Inc. purchased a new position in shares of CME Group during the 2nd quarter valued at approximately $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of CME Group during the 2nd quarter valued at approximately $629,771,000. 87.75% of the stock is owned by institutional investors and hedge funds.
Recent CME Group Headlines
These are some of the CME headlines that stood out recently:
- Neutral Sentiment: Several reports focus on CME Group’s LPGA Tour Championship sponsorship and tournament coverage. This may support brand visibility, but no direct near-term financial impact was reported. Article
- Negative Sentiment: Duffy sold 27,000 shares for about $8.36 million, reducing his direct stake by 43.24%. General Counsel John Clifford Marchese also sold 655 shares, an 18.20% reduction in his holdings. Insider sales can be made for personal reasons and do not necessarily signal a change in company outlook, but the CEO’s sale may weigh on sentiment. CEO filing General counsel filing
- Negative Sentiment: A valuation-focused report says CME shares may be fully valued after a 69% run, raising the risk that expectations are already reflected in the price. Article
CME Group Price Performance
Shares of NASDAQ CME opened at $306.31 on Friday. The firm has a market cap of $109.64 billion, a PE ratio of 25.13, a PEG ratio of 3.79 and a beta of 0.15. The firm has a fifty day moving average of $288.79 and a 200 day moving average of $282.00. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.99 by $0.03. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The business had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.71 billion. During the same period last year, the firm posted $2.68 earnings per share. The company’s revenue was up 10.6% compared to the same quarter last year. As a group, research analysts predict that CME Group Inc. will post 12.35 EPS for the current fiscal year.
CME Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 30th. Investors of record on Friday, December 11th will be given a dividend of $1.30 per share. The ex-dividend date of this dividend is Friday, December 11th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. CME Group’s dividend payout ratio (DPR) is presently 42.66%.
Insider Transactions at CME Group
In other CME Group news, insider Julie Winkler sold 10,079 shares of the business’s stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $305.15, for a total value of $3,075,606.85. Following the sale, the insider owned 21,482 shares of the company’s stock, valued at $6,555,232.30. The trade was a 31.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Terrence Duffy sold 27,000 shares of the company’s stock in a transaction on Wednesday, November 18th. The stock was sold at an average price of $309.57, for a total value of $8,358,390.00. Following the transaction, the chief executive officer owned 35,442 shares in the company, valued at $10,971,779.94. This trade represents a 43.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 61,166 shares of company stock worth $18,276,512 in the last three months. Company insiders own 0.30% of the company’s stock.
Analyst Ratings Changes
A number of analysts recently issued reports on the stock. Wall Street Zen raised shares of CME Group from a “sell” rating to a “hold” rating in a report on Saturday, October 31st. Bank of America lifted their price objective on shares of CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a report on Thursday, July 23rd. Barclays upped their price objective on shares of CME Group from $281.00 to $321.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 22nd. Deutsche Bank lowered shares of CME Group from a “buy” rating to a “hold” rating and lowered their target price for the stock from $286.00 to $270.00 in a research note on Wednesday, August 19th. Finally, CLSA set a $367.00 price target on CME Group in a research note on Thursday, October 22nd. Ten analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $314.44.
View Our Latest Report on CME Group
CME Group Profile
CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.
See Also
- Five stocks we like better than CME Group
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
